Redefining clinical risk classification in children with precursor B cell acute lymphoblastic leukemia using pre-treatment absolute lymphocyte count

Leuk Lymphoma. 2016;57(4):953-6. doi: 10.3109/10428194.2015.1081194. Epub 2015 Oct 12.

Authors

Patcharapan Fungpipat¹, Jiratchaya Sophonphan², Darintr Sosothikul¹, Koramit Suppipat¹

Affiliations

¹ a Pediatric Hematology and Oncology Unit, Department of Pediatrics , Faculty of Medicine, Chulalongkorn University , Bangkok , Thailand and.
² b Department of Biostatistics , HIV-NAT Research Collaboration, Thai Red Cross AIDS Research Center , Bangkok , Thailand.

PMID: 26292611
DOI: 10.3109/10428194.2015.1081194

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Child
Child, Preschool
Humans
Infant
Kaplan-Meier Estimate
Lymphocyte Count*
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / diagnosis*
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / mortality
Precursor Cells, B-Lymphoid / pathology*
Prognosis
Risk Assessment
Risk Factors